TECHi.com
Overview for PFE coming soon.
Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy
NYSE · Healthcare · Profile
Pfizer, Inc. (PFE) stock profile and business model
What Pfizer, Inc. does, how the business earns money, and how valuation, peers, ownership, and risk shape the TECHi profile.
Section freshness
Price Aug 19, 2:00 PM EDT · Statements Jun 27, 8:00 PM EDT
Investor profile snapshot
PFE live price, business model and key metrics
Start with the live market print, then use this profile to connect Pfizer, Inc.'s operating model with revenue, margins, peer context, and investor risk.
RealtimeRealtime regular-session pricing
$28.17
▲ +$0.9150(+3.36%)2:00 PM ET - vs previous closeiQuote as of Aug 19, 2026, 2:00 PM EDT
Realtime NYSE quote as of Aug 19, 2026, 2:00 PM EDT.
Market data source
Today68%
$27.58L Aug 19 '26$28.44H Aug 19 '26
52-week89%
$23.58$28.75
Long-term ranges5Y, 10Y, Since first printHide
5Y18%
$20.92L Apr 9 '25$61.71H Dec 20 '21
10Y18%
$20.92L Apr 9 '25$61.71H Dec 20 '21
Since first print34%
$11.02L Mar 2 '09$61.71H Dec 20 '21
Live price
$28.17
Live during market hours
Market cap
$160.50B
Equity scale
Analyst view
Hold
Target $28.61 (+1.56% implied)
Company · Profile
About Pfizer, Inc. (PFE)
Sector, leadership, and how Pfizer, Inc. earns its revenue.
Healthcare
Company · Profile
About Pfizer, Inc. (PFE)
Sector, leadership, and how Pfizer, Inc. earns its revenue.
Pfizer, Inc.
NYSE · PFE · US
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Country
- US
- Founded
- 1999
- Exchange
- NYSE
Business identity
Pfizer, Inc. company facts and operating footprint
Overview for PFE coming soon.
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Founded
- 1999
- Country
- US
- Exchange
- NYSE
Registration and filing identifiersShowHide
- Asset type
- Common Stock
- Fiscal year end
- December
- Latest quarter
- Jun 28, 2026
- CIK
- 0000078003
Key metrics
PFE valuation, revenue and margin profile
- Market cap
- $160.50B
- Equity scale
- Net margin
- 4.72%
- Profit after expenses
- Free cash flow
- $302.00M
- Reported in USD
Margin quality snapshot
Net margin4.72%
Competitors
PFE competitors and peer context
Risk heatmap
PFE business risks investors should monitor
Valuation sensitivity
Elevated37.05x
Use the forward P/E and PEG context before treating the profile as cheap or expensive.
Balance-sheet flexibility
MonitorD/E 0.74 · CR 1.27
Debt load and near-term liquidity shape how much strategic patience the company has.
Growth durability
Monitor—
Latest YoY revenue growth is the first check on whether the business model is still expanding.
Market sensitivity
MonitorBeta 0.28
Higher beta can amplify drawdowns when rates, earnings expectations, or sector appetite shift.
Regulatory and operating pressure
ElevatedHealthcare
Clinical, reimbursement, approval, and policy shifts can change revenue timing and product economics.
PFE ownership and registration profile
- Float shares
- 5.69B
- Insider ownership
- 0.10%
- Institutional ownership
- 69.14%
Size & scale
- Market cap
- $160.50B
- Enterprise value
- $222.72B
- Shares outstanding
- 5.70B
- Currency
- USD
Frequently asked
Common questions.
What does Pfizer, Inc. do?
The PFE Profile page keeps the available company description, sector, industry, leadership, headquarters, workforce, and product context together.
Where does TECHi source the PFE profile?
Profile fields come from the unified company record and provider data; unavailable identity fields remain blank rather than inferred.